Marshall Wace, LLP Invitae Corp Transaction History

Marshall Wace, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $6.08 Million - $15.1 Million	-968,587 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$14.7 - $28.67 $14.2 Million - $27.8 Million	968,587 New	968,587 $14.8 Million
Q2 2021 Aug 13, 2021	SELL	$26.09 - $40.4 $19.6 Million - $30.4 Million	-752,679 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$33.06 - $56.93 $9.77 Million - $16.8 Million	-295,670 Reduced 28.2%	752,679 $28.8 Million
Q4 2020 Feb 16, 2021	BUY	$39.09 - $57.4 $41 Million - $60.2 Million	1,048,349 New	1,048,349 $43.8 Million
Q2 2020 Aug 13, 2020	SELL	$11.71 - $30.29 $1.01 Million - $2.6 Million	-85,928 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$7.64 - $27.5 $656,489 - $2.36 Million	85,928 New	85,928 $1.18 Million
Q1 2019 May 14, 2019	SELL	$10.65 - $25.75 $968,649 - $2.34 Million	-90,953 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$9.26 - $16.38 $842,224 - $1.49 Million	90,953 New	90,953 $1.01 Million

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.